Related Experiment Video
Updated: Jan 20, 2026

Digital Droplet PCR Method for the Quantification of AAV Transduction Efficiency in Murine Retina
Published on: December 25, 2021
AAV-ie enables safe and efficient gene transfer to inner ear cells
Fangzhi Tan1, Cenfeng Chu2,3,4, Jieyu Qi5,6
1iHuman Institute, ShanghaiTech University, 201210, Shanghai, China. tanfzh@shanghaitech.edu.cn.
Researchers developed a new Adeno-associated virus (AAV) variant, AAV-inner ear (AAV-ie), for gene therapy. This novel vector efficiently delivers genes to mouse inner ear cells, enabling hair cell regeneration for hearing loss treatment.
Area of Science:
- Otolaryngology
- Gene Therapy
- Regenerative Medicine
Background:
- Hearing loss is a prevalent sensory disorder, often stemming from genetic causes.
- Gene therapy offers a promising avenue for treating inherited hearing loss, but requires effective gene delivery vectors.
- Current Adeno-associated virus (AAV) vectors lack efficiency and specificity for targeting diverse inner ear cell types.
Purpose of the Study:
- To identify and characterize a novel Adeno-associated virus (AAV) variant for enhanced gene delivery within the mouse inner ear.
- To evaluate the efficacy of the identified AAV variant in transducing cochlear supporting cells (SCs).
- To investigate the potential of AAV-mediated gene transfer for hair cell (HC) regeneration.
Main Methods:
- Isolation and characterization of a novel AAV variant, designated AAV-inner ear (AAV-ie).
- Assessment of AAV-ie's transduction efficiency in mouse cochlear supporting cells (SCs).
- In vivo gene transfer of the Atoh1 gene using AAV-ie, followed by analysis of SCs' trans-differentiation into hair cells (HCs).
Main Results:
- AAV-ie demonstrated high transduction efficiency in mouse cochlear supporting cells (SCs), significantly outperforming conventional AAV serotypes.
- Atoh1 gene transfer mediated by AAV-ie successfully induced trans-differentiation of SCs into new hair cells (HCs).
- The study highlights AAV-ie's potential as a superior tool for cochlear gene therapy.
Conclusions:
- AAV-inner ear (AAV-ie) represents a significant advancement in Adeno-associated virus (AAV) vector technology for inner ear gene delivery.
- AAV-ie facilitates efficient gene transfer to cochlear supporting cells, paving the way for novel therapeutic strategies for hearing loss.
- This vector is valuable for both cochlear gene therapy and for elucidating mechanisms of hair cell regeneration.
More Related Videos
Related Concept Videos
Horizontal Gene Transfer
Cell Specific Gene Expression
Anatomy of the Ear
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:
Types of Genetic Transfer Between Organisms
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...

